Syra Health Company Insiders
| SYRA Stock | USD 0.08 0.01 12.34% |
About 86 percent of all Syra Health's insiders are aggressively buying. The analysis of insiders' sentiment of trading Syra Health Corp stock suggests that a fairly large number of insiders are very bullish at this time. Syra Health employs about 57 people. The company is managed by 8 executives with a total tenure of roughly 133 years, averaging almost 16.0 years of service per executive, having 7.13 employees per reported executive.
Insider Sentiment 86
Aggressively Buying
Selling | Buying |
Latest Trades
| 2024-09-12 | Priya Prasad | Acquired 5303 @ 0.38 | View | ||
| 2024-02-08 | Priya Prasad | Disposed 500 @ 7.5 | View | ||
| 2023-12-21 | Priya Prasad | Acquired 1 @ 1.18 | View | ||
| 2023-12-13 | Sandeep Allam | Acquired 647 @ 1.4 | View | ||
| 2023-12-11 | Sandeep Allam | Acquired 362 @ 1.37 | View | ||
| 2023-12-08 | Priya Prasad | Acquired 50 @ 1.23 | View | ||
| 2023-12-07 | Sandeep Allam | Acquired 206 @ 1.27 | View | ||
| 2023-12-06 | Priya Prasad | Acquired 50 @ 1.22 | View | ||
| 2023-12-05 | Sandeep Allam | Acquired 1145 @ 1.32 | View | ||
| 2023-12-04 | Priya Prasad | Acquired 4271 @ 1.14 | View | ||
| 2023-12-01 | Priya Prasad | Acquired 435 @ 1.23 | View | ||
| 2023-11-28 | Sandeep Allam | Acquired 60 @ 1.22 | View | ||
| 2023-10-09 | Priya Prasad | Acquired 1000 @ 2.66 | View | ||
| 2023-10-05 | Priya Prasad | Disposed 918 @ 3.19 | View | ||
| 2023-09-29 | Priya Prasad | Acquired 918 @ 3.3 | View |
Monitoring Syra Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Syra Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. Syra Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.2065) % which means that it has lost $0.2065 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4571) %, meaning that it created substantial loss on money invested by shareholders. Syra Health's management efficiency ratios could be used to measure how well Syra Health manages its routine affairs as well as how well it operates its assets and liabilities. As of February 5, 2026, Return On Tangible Assets is expected to decline to -0.97. In addition to that, Return On Capital Employed is expected to decline to -1.48. The current year's Other Assets is expected to grow to 1,208, whereas Total Assets are forecasted to decline to about 2.5 M.As of February 5, 2026, Common Stock Shares Outstanding is expected to decline to about 7.2 MSyra Health Corp maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Some institutional investors establish a significant position in stocks such as Syra Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Syra Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Syra Health Workforce Comparison
Syra Health Corp is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,236. Syra Health holds roughly 57.0 in number of employees claiming about 5% of equities under Health Care industry.
Syra Health Profit Margins
The company has Profit Margin (PM) of (0.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.26 | 0.24 |
|
|
Syra Health Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Syra Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Syra Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Syra Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Gregory Alexander over a month ago Insider Trading | ||
Reddy Avutu over two months ago Acquisition by Reddy Avutu of 15442 shares of Syra Health at 0.3683 subject to Rule 16b-3 | ||
Reddy Avutu over two months ago Acquisition by Reddy Avutu of 43348 shares of Syra Health at 0.07 subject to Rule 16b-3 | ||
Deepika Vuppalanchi over three months ago Disposition of tradable shares by Deepika Vuppalanchi of Syra Health subject to Rule 16b-3 | ||
Rogers Sherron over a year ago Insider Trading | ||
Dahlem Andrew over a year ago Acquisition by Dahlem Andrew of 11581 shares of Syra Health at 0.3683 subject to Rule 16b-3 | ||
Feroz Syed over a year ago Acquisition by Feroz Syed of 320 shares of Syra Health at 1.34 subject to Rule 16b-3 | ||
Feroz Syed over a year ago Disposition of tradable shares by Feroz Syed of Syra Health subject to Rule 16b-3 |
Syra Health Notable Stakeholders
A Syra Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Syra Health often face trade-offs trying to please all of them. Syra Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Syra Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Priya Prasad | CFO, CEO | Profile | |
| Deepika Vuppalanchi | CEO CoFounder | Profile | |
| Sandeep Allam | Executive President | Profile | |
| Christine Drury | Communications Director | Profile | |
| Eric Crispell | Senior Director | Profile | |
| Jacop Lucas | Senior Operations | Profile | |
| Gregory Alexander | Chief Officer | Profile | |
| Feroz Syed | Principal Corp | Profile |
About Syra Health Management Performance
The success or failure of an entity such as Syra Health Corp often depends on how effective the management is. Syra Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Syra management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Syra management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.92) | (0.97) | |
| Return On Capital Employed | (1.41) | (1.48) | |
| Return On Assets | (0.92) | (0.97) | |
| Return On Equity | (1.50) | (1.58) |
Please note, the presentation of Syra Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Syra Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Syra Health's management manipulating its earnings.
Syra Health Workforce Analysis
Traditionally, organizations such as Syra Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Syra Health within its industry.Syra Health Manpower Efficiency
Return on Syra Health Manpower
| Revenue Per Employee | 140K | |
| Revenue Per Executive | 997.8K | |
| Net Loss Per Employee | 66K | |
| Net Loss Per Executive | 469.9K | |
| Working Capital Per Employee | 48.1K | |
| Working Capital Per Executive | 342.4K |
Complementary Tools for Syra Stock analysis
When running Syra Health's price analysis, check to measure Syra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syra Health is operating at the current time. Most of Syra Health's value examination focuses on studying past and present price action to predict the probability of Syra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syra Health's price. Additionally, you may evaluate how the addition of Syra Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |